Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies

Davis M. SeeligDepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, USA; ;Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA;

Daisuke ItoDepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, USA; ;Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA;

Colleen L. ForsterThe University of Minnesota Biological Materials Procurement Network (BioNet), University of Minnesota, Minneapolis, MN, USA;

Una A. YoonDepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, USA;

Matthew BreenDepartment of Molecular Biomedical Sciences, College of Veterinary Medicine, Center for Comparative Medicine and Translational Research, North Carolina State University, Raleigh, NC, USA; ;Cancer Genetics Program, University of North Carolina Lineberger Comprehensive Cancer Center, Raleigh, NC, USA;

Linda J. BurnsMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; ;Department of Medicine, Division of Hematology, Oncology, and Transplantation, School of Medicine, University of Minnesota, Minneapolis, MN, USA;

Veronika BachanovaMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; ;Department of Medicine, Division of Hematology, Oncology, and Transplantation, School of Medicine, University of Minnesota, Minneapolis, MN, USA;

Kerstin Lindblad-TohBroad Institute of MIT and Harvard, Cambridge, MA, USA; ;Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;

Timothy D. O’BrienDepartment of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, USA; ;Stem Cell Institute, University of Minnesota, Minneapolis, MN, USA;

Stephen C. SchmechelDepartment of Pathology, University of Washington, Seattle, WA, USA;

Anthony E. RizzardiDepartment of Pathology, University of Washington, Seattle, WA, USA;

Jaime F. ModianoDepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, USA; ;Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; ;Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, USA; ;Stem Cell Institute, University of Minnesota, Minneapolis, MN, USA; ;Center for Immunology, University of Minnesota, Minneapolis, MN, USA;

Michael A. LindenMasonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; ;Department of Laboratory Medicine and Pathology, Division of Hematopathology, School of Medicine, University of Minnesota, Minneapolis, MN, USACorrespondence[email protected]

show all

Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date